OTCMKTS:CZMWY Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis $66.92 +1.54 (+2.36%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$66.19▼$67.2850-Day Range$65.37▼$103.1652-Week Range$64.64▼$134.60Volume9,254 shsAverage Volume3,105 shsMarket CapitalizationN/AP/E Ratio72.74Dividend Yield0.45%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Get Carl Zeiss Meditec alerts: Email Address Carl Zeiss Meditec MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthyDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.50Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.98 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Carl Zeiss Meditec.Read more about Carl Zeiss Meditec's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverCarl Zeiss Meditec has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Carl Zeiss Meditec has recently decreased by 69.23%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldCarl Zeiss Meditec pays a meaningful dividend of 1.36%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCarl Zeiss Meditec does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Carl Zeiss Meditec is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Carl Zeiss Meditec's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CZMWY. Previous Next 1.9 News and Social Media Coverage News SentimentCarl Zeiss Meditec has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Carl Zeiss Meditec this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.10% of the stock of Carl Zeiss Meditec is held by institutions.Read more about Carl Zeiss Meditec's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Carl Zeiss Meditec is 72.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.26.Price to Earnings Ratio vs. SectorThe P/E ratio of Carl Zeiss Meditec is 72.74, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 169.33. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Carl Zeiss Meditec Stock (OTCMKTS:CZMWY)Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More CZMWY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CZMWY Stock News HeadlinesJuly 21, 2024 | finance.yahoo.comAn Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 37% UndervaluedMay 6, 2024 | finance.yahoo.comDeclining Stock and Solid Fundamentals: Is The Market Wrong About Carl Zeiss Meditec AG (ETR:AFX)?July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 22, 2024 | finance.yahoo.comWhat Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?March 25, 2024 | finance.yahoo.comCarl Zeiss Meditec's (ETR:AFX) investors will be pleased with their respectable 63% return over the last five yearsMarch 21, 2024 | msn.comCarl Zeiss Meditec AG goes ex dividend tomorrowFebruary 29, 2024 | finance.yahoo.comInstitutions own 23% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the companyFebruary 13, 2024 | finance.yahoo.comCarl Zeiss Meditec AG (CZMWY)July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.January 26, 2024 | seekingalpha.comCarl Zeiss: We've Seen Outperformance, But I See More Upside PotentialJanuary 11, 2024 | finanznachrichten.deCarl Zeiss Meditec AG: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISSDecember 19, 2023 | msn.comCarl Zeiss Meditec to acquire Dutch Ophthalmic for around $1.08BDecember 18, 2023 | finance.yahoo.comCarl Zeiss Meditec Full Year 2023 Earnings: EPS Beats ExpectationsDecember 15, 2023 | markets.businessinsider.comEQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)December 15, 2023 | markets.businessinsider.comEQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.December 15, 2023 | finance.yahoo.comCarl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)December 15, 2023 | finance.yahoo.comZeiss Meditec buys Dutch firm for nearly 1 bln eurosNovember 27, 2023 | finance.yahoo.comAre Strong Financial Prospects The Force That Is Driving The Momentum In Carl Zeiss Meditec AG's ETR:AFX) Stock?See More Headlines Receive CZMWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CZMWY CUSIPN/A CIKN/A Webwww.zeiss.com Phone493641220115FaxN/AEmployees4,823Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio72.74 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Markus WeberCEO & Chairman of Management BoardMr. Justus Felix Wehmer (Age 59)CFO & Member of the Management Board Comp: $650.23kDr. Christian Munster (Age 53)Head of Global Regulatory & Clinical Affairs, CoCe Site Jena & Emp. Rep. Member of Supervisory Board Stefanie SpanagelChief Operating OfficerMr. Sebastian FrericksDirector of Investor RelationsEva-Maria HeineChief Human Resources OfficerMr. Steven C. Schallhorn M.D.Chief Medical Officer for Global Ophthalmic DevicesMr. Andrew ChangHead of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec, Inc.Dr. Euan S. Thomson Ph.D. (Age 61)President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit Mr. Magnus ReibenspiessHead of the Microsurgery Strategic Business Unit - ZEISS Medical TechnologyMore ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors CZMWY Stock Analysis - Frequently Asked Questions How have CZMWY shares performed this year? Carl Zeiss Meditec's stock was trading at $109.1439 at the beginning of 2024. Since then, CZMWY stock has decreased by 38.7% and is now trading at $66.9164. View the best growth stocks for 2024 here. How do I buy shares of Carl Zeiss Meditec? Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CZMWY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Carl Zeiss Meditec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
